Publications & Presentations

Publications & Presentations

The information in our publications and presentations should be considered accurate only as of the date of the publications or presentations. We disclaim any obligation to supplement or update the information in these publications and presentations.

To learn more about our innovative technology:
Early prediction of response to INP104 for the acute treatment of migraine

Presented at the AHS Annual Scientific Meeting, June 9–12, 2022 Authors: Sacco, S.; Vann, R.; Lieu, T.; Ray, S.; Shrewsbury, S.B.; Aurora, S.K. One sentence summary: Patients who self-reported mild or no pain at 2 hours for their first 2…

READ MORE

Improvements in productivity and disability with INP104 as assessed by the Migraine Disability Assessment Scale (MIDAS): Results from the phase 3 STOP 301 study

Presented at the AHS Annual Scientific Meeting, June 9–12, 2022 Authors: Treppendahl, C.; Buse, D.C.; Vann, R.; Fitzpatrick, C.; Murphy, M.; Shrewsbury, S.B.; Aurora, S.K. One sentence summary: Long-term INP104 use was associated with improvements in scores of several individual…

READ MORE

Exploratory efficacy of INP104 in patients using concomitant preventive migraine medications

Presented at the AHS Annual Scientific Meeting, June 9–12, 2022 Authors: Grant, J.; Vann, R.; Fitzpatrick, C.; Lieu, T.; Shrewsbury, S.B.; Aurora, S.K. One sentence summary: INP104 was associated with improvements in self-reported exploratory efficacy in patients who did or…

READ MORE